an update on the summit trial: bezuclastinib in non-advanced systemic mastocytosis
Published 1 month ago • 128 plays • Length 3:46Download video MP4
Download video MP3
Similar videos
-
3:54
summit study: safety & efficacy of bezuclastinib in patients with nonadvanced systemic mastocytosis
-
1:46
updated analyses from the pathfinder trial: avapritinib therapy in advanced systemic mastocytosis
-
1:27
ongoing trials and novel agents being explored in advanced and indolent systemic mastocytosis
-
5:21
systemic mastocytosis: current treatments and emerging targeted agents
-
2:56
insights into the treatment and management of advanced systemic mastocytosis
-
2:21
avapritinib updates in advanced systemic mastocytosis: explorer and pioneer
-
1:41
the current therapeutic landscape for indolent and advanced systemic mastocytosis
-
2:15
mars: mutation-adjusted risk score for advanced systemic mastocytosis
-
9:56
mast cells | normal role, allergies, anaphylaxis, mcas & mastocytosis.
-
5:16
is it systemic mastocytosis? best practices for diagnosis and management – patient video
-
45:36
mast cell activation syndrome: the functional medicine approach
-
1:46
unmet needs and challenges in advanced systemic mastocytosis
-
3:10
pioneer trial update: avapritinib for indolent systemic mastocytosis
-
0:52
the unmet needs that remain for patients with systemic mastocytosis
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
3:05
explorer: avapritinib in systemic mastocytosis
-
4:46
management strategies for advanced systemic mastocytosis
-
1:10
avapritinib for advanced systemic mastocytosis: analysis of patient-reported outcomes from explorer
-
1:44
emerging novel agents for the treatment of mastocytosis
-
1:26
the future of jak inhibition for mpns
-
24:40
updates in advanced systemic mastocytosis from eha 2022: clinical case presentation
-
2:41
an overview of the latest advances in hematology